EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression

BACKGROUND: Currently, the nonsmall-cell lung cancer (NSCLC) is a worldwide disease, which has very poor influence on life quality, whereas the therapeutic effects of drugs for it are not satisfactory. The aim of our PRISMA-compliant systematic review and meta-analysis was to compare the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Na, Zhang, Yingshi, Niu, Huibin, Li, Zuojing, Cai, Jiayi, Zhao, Qingchun, Li, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268044/
https://www.ncbi.nlm.nih.gov/pubmed/27977598
http://dx.doi.org/10.1097/MD.0000000000005601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268044/
https://www.ncbi.nlm.nih.gov/pubmed/27977598
http://dx.doi.org/10.1097/MD.0000000000005601

Ejemplares similares